原始版与修订版骨报告和数据系统(Bone-RADS)的性能与可靠性比较
本回顾性研究纳入159例因孤立性骨病变行骨活检的成人患者,比较修订版与原始版Bone-RADS在CT上的诊断性能与阅片者间可靠性。修订版去除了病灶相关疼痛和恶性肿瘤病史标准。修订版特异度显著高于原始版(溶骨性病变阅片者1为50% vs 11%,阅片者2为46% vs 11%;硬化/混合性病变阅片者1为92% vs 32%,阅片者2为86% vs 32%),敏感度无显著差异,阅片者间可靠性更高(κ=0.854 vs 0.744)。
要点
- 修订版Bone-RADS去除病灶相关疼痛和恶性肿瘤病史标准后,特异度显著提高而敏感度保持不变。
- 溶骨性病变特异度:原始版阅片者1为11%、阅片者2为11%,修订版阅片者1为50%、阅片者2为46%。
- 硬化/混合性病变特异度:原始版阅片者1为32%、阅片者2为32%,修订版阅片者1为92%、阅片者2为86%。
核心结论
- 与原始版相比,修订版Bone-RADS在保持敏感度的同时显著提高了特异度,并提高了阅片者间可靠性。
研究设计与样本
- 回顾性研究,纳入2005年3月至2021年9月间因孤立性骨病变行骨活检的159例成人患者(平均年龄56±19岁,88例男性),以组织病理学为参考标准,两名放射科医师独立使用原始版和修订版Bone-RADS对病变各分类两次。
关键影像表现/征象
- 骨病变包括96个溶骨性病变和63个硬化/混合性病变。
- 修订版Bone-RADS去除了原始版中病灶相关疼痛和恶性肿瘤病史两项标准。
- 病变分类为:1类良性;2类评估不完整;3类不确定;4类恶性或需治疗。
诊断标准与关键数值
- 敏感度在原始版与修订版之间无显著差异(所有P≥.05),覆盖两名阅片者及溶骨性和硬化/混合性病变。
- 溶骨性病变特异度:原始版阅片者1为11%、阅片者2为11%,修订版阅片者1为50%、阅片者2为46%。
- 硬化/混合性病变特异度:原始版阅片者1为32%、阅片者2为32%,修订版阅片者1为92%、阅片者2为86%。
- 修订版的其他性能指标(阳性预测值、阴性预测值和准确率)也高于原始版。
- 阅片者间可靠性:修订版κ=0.854,原始版κ=0.744。
临床应用与阅片要点
- 修订版Bone-RADS去除了病灶相关疼痛和恶性肿瘤病史标准,可提高CT上孤立性骨病变分类的特异度。
- 修订版在保持敏感度的同时提高特异度,并具有更高的阅片者间可靠性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To propose a revised bone reporting and data system (Bone-RADS) and evaluate its diagnostic performance and inter-reader reliability compared to the original Bone-RADS for solitary bone lesions on CT.
MATERIALS AND METHODS: This retrospective study included 159 adult patients (mean age: 56 ± 19 years; 88 men) who underwent bone biopsy for solitary bone lesions between March 2005 and September 2021. Two radiologists (R1/2) independently categorized the lesions twice, once using the original Bone-RADS and once using the revised version. Lesions were classified as follows: (1, benign; 2, incompletely assessed; 3, indeterminate; 4, malignancy or requiring treatment). The revised Bone-RADS excluded the original criteria for lesion related pain and history of malignancy. Diagnostic performance was assessed using histopathology as the reference standard, and inter-reader reliability was analyzed.
RESULTS: The bone lesions included 96 lucent and 63 sclerotic/mixed lesions. Sensitivity showed no significant difference between the original and revised Bone-RADS for both readers across lucent and sclerotic/mixed lesions (all P ≥ .05). However, the specificity of the revised Bone-RADS was significantly higher than that of the original (lucent: 11% vs. 50% [R1], 11% vs. 46% [R2]; sclerotic/mixed: 32% vs. 92% [R1], 32% vs. 86% [R2]). Other performance metrics, including positive/negative predictive value and accuracy, were also higher in the revised Bone-RADS. Inter-reader reliability was higher for the revised Bone-RADS compared to the original (κ = .744 vs .854).
CONCLUSION: The revised Bone-RADS significantly improved specificity while maintaining sensitivity compared to the original version.
引用
- Haseli S, Park C, Azhideh A, et al. Performance and reliability comparison: original vs. revised bone reporting and data system (Bone-RADS). Skeletal Radiol. 2025. PMID: 39838067. doi:10.1007/s00256-025-04865-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。